KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Other financing activities (2016 - 2025)

Historic Other financing activities for Regeneron Pharmaceuticals (REGN) over the last 9 years, with Q1 2025 value amounting to -$10.3 million.

  • Regeneron Pharmaceuticals' Other financing activities changed N/A to -$10.3 million in Q1 2025 from the same period last year, while for Dec 2025 it was -$10.3 million, marking a year-over-year increase of 6916.17%. This contributed to the annual value of -$10.3 million for FY2025, which is 6916.17% up from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Other financing activities stood at -$10.3 million for Q1 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Other financing activities registered a high of -$10.3 million during Q1 2025, and its lowest value of -$33.4 million during Q3 2024.